%0 Journal Article
%T A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors.
%A Castelli M
%A Betelli M
%A Valenti A
%A Merelli B
%A Loglio A
%A Viganò M
%A Benetti A
%J Eur J Case Rep Intern Med
%V 11
%N 7
%D 2024
%M 38984185
暂无%R 10.12890/2024_004237
%X We describe a rare case of polyserositis with chylous ascites following nivolumab therapy, highlighting the challenges in recognising and managing immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICPIs). Induced polyserositis and chylous ascites are very rare and require immunosuppressive treatment, with a variable response of high-dose IV steroids.<BR><B>CONCLUSIONS: </B>Oncological therapy with immune checkpoint inhibitors (ICPIs) is frequently associated with immune-related adverse events (irAEs) most involving cutaneous, gastrointestinal and pulmonary sites.